Meeting
2022 ASCO Genitourinary Cancers Symposium
Association of renal cell carcinoma (RCC) metastatic to pancreas with a distinct molecular profile and immune cell population.
Authors
Ryan S. Chiang
Stanford University Medical Center, Stanford, CA
Ryan S. Chiang , Arya Ashok , Elizabeth Mauer , Alex Barrett , Christian R Hoerner , Osama A Khan , Chia-Sui Kao , Sumit Shah , Sandy Srinivas , Alice C. Fan , Ali Raza Khaki
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral, and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 366)
DOI
10.1200/JCO.2022.40.6_suppl.366
Abstract #
366
Poster Bd #
G12
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
NRG-GU012: Randomized phase II stereotactic ablative radiation therapy (SABR) for patients with metastatic unresected renal cell carcinoma (RCC) receiving immunotherapy (SAMURAI).
First Author: William A. Hall
Poster
2023 ASCO Genitourinary Cancers Symposium
Mapping distribution of brain metastases in renal cell carcinoma (RCC) and association with clinical features.
First Author: Yasser Ged
Poster
2023 ASCO Gastrointestinal Cancers Symposium
A phase II study of hypofractionated radiation therapy to augment immune response in patients with metastatic gastrointestinal malignancies progressing on immune therapy (ARM-GI).
First Author: Hewitt Chang
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Clinical outcomes for IDH1 mutant biliary tract cancer (BTC) treated with contemporary systemic therapy.
First Author: Darren Cowzer